Singh, Awadhesh Kumar <br/><br/>
Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences.  [electronic resource] 

 -  Expert review of clinical pharmacology  2016 
 - 229-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1751-2441 
<br/><br/><label>Standard No.: </label>10.1586/17512433.2016.1123616  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--administration & dosage<br/>Drug Therapy, Combination<br/>Glucose--metabolism<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Sodium-Glucose Transporter 2 Inhibitors